NCT04181333 2026-04-14
Safety and Efficacy of Trastuzumab BS
Pfizer
Completed
Clinical Trials
100 trialsNCT05105100 2026-04-06
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
Completed
NCT04822350 2026-04-02
AVENANCE
Pfizer
Completed
NCT05076266 2026-04-02
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Eastern Cooperative Oncology Group
Terminated
NCT02348684 2026-04-01
Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Medical College of Wisconsin
Completed
NCT03398915 2026-03-31
EUROSPIN
Bergman Clinics
Active not recruiting
NCT05561920 2026-03-31
Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
Osijek University Hospital
Completed
NCT02362750 2026-03-25
Evaluating Cancer Survivorship Care Models
George Washington University
Completed
NCT05510908 2026-03-25
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
Completed
NCT04877912 2026-03-20
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
University of Chicago
Terminated
NCT04539327 2026-03-18
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
Completed
NCT06221397 2026-03-16
LEGIT_MC_EVCDA
AI Labs Group S.L
Completed
NCT03516942 2026-03-13
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Eastern Cooperative Oncology Group
Active not recruiting
NCT06282991 2026-03-10
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
Completed
NCT05968599 2026-02-25
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
Completed
NCT06837090 2026-02-20
SPAINTRK
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT05383976 2026-02-11
PCSNaP
Abramson Cancer Center at Penn Medicine
Completed
NCT05079334 2026-02-10
FOREST
Vanderbilt University Medical Center
Active not recruiting
NCT06018376 2026-02-06
LUDICAS
Fundación GECP
Completed
NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT05622682 2026-01-26
VIRAL
Children's Hospital of Philadelphia
Completed
NCT04514341 2026-01-14
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
Milton S. Hershey Medical Center
Completed
NCT01004952 2026-01-07
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
Memorial Sloan Kettering Cancer Center
Completed
NCT04872738 2026-01-06
LymphVAX
Massachusetts General Hospital
Completed
NCT05529979 2026-01-06
SaFE
Quantum Surgical
Completed
NCT04317599 2026-01-02
CAPSTAN CRC
Pierre Fabre Medicament
Completed
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT06072196 2025-12-31
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT01827956 2025-12-29
FCR-VADS
Institut Bergonié
Completed
NCT04369053 2025-12-26
PREEMPT CRC
Freenome Holdings Inc.
Completed
NCT04131933 2025-12-23
REaCT-Algorith
Ottawa Hospital Research Institute
Completed
NCT01440465 2025-12-17
NAVI
Centre Francois Baclesse
Completed
NCT03912376 2025-12-15
A Study of a Device Used to Take Pictures of Skin Blood Flow
Memorial Sloan Kettering Cancer Center
Completed
NCT01440010 2025-12-12
TARGIT_BQR
Universitätsmedizin Mannheim
Completed
NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
NCT06462014 2025-12-11
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Pfizer
Completed
NCT03359759 2025-12-10
e-DomSanté
Institut Bergonié
Completed
NCT03676010 2025-12-10
DATECAN-1
Institut Bergonié
Active not recruiting
NCT03676257 2025-12-10
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Institut Bergonié
Completed
NCT03963531 2025-12-10
METABONE
Institut Bergonié
Completed
NCT03963544 2025-12-10
METAGIST
Institut Bergonié
Completed
NCT04671615 2025-12-10
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
Pfizer
Completed
NCT04735367 2025-12-09
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Pfizer
Completed
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT02326064 2025-12-02
TORCH
Centre Hospitalier Departemental Vendee
Completed
NCT05366725 2025-12-02
A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT04941768 2025-11-28
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT02263014 2025-11-26
Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
M.D. Anderson Cancer Center
Active not recruiting
NCT06086340 2025-11-18
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Pfizer
Completed